Discontinued — last reported Q4 '21
Arthur J. Gallagher Short-Term Borrowings remained flat by 0.0% to $640.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 24.3%, from $515.00M to $640.00M. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows an upward trend with a 53.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $200.00M | $200.00M | $245.00M | $250.00M | $710.00M | $440.00M | $310.00M | $675.00M | $920.00M | $425.00M | $670.00M | $108.20M | $280.00M | $200.00M | $200.00M | $515.00M | $640.00M | $770.00M | $640.00M | $640.00M |
| QoQ Change | — | +0.0% | +22.5% | +2.0% | +184.0% | -38.0% | -29.5% | +117.7% | +36.3% | -53.8% | +57.6% | -83.9% | +158.8% | -28.6% | +0.0% | +157.5% | +24.3% | +20.3% | -16.9% | +0.0% |
| YoY Change | — | — | — | — | +255.0% | +120.0% | +26.5% | +170.0% | +29.6% | -3.4% | +116.1% | -84.0% | -69.6% | -52.9% | -70.1% | +376.0% | +128.6% | +285.0% | +220.0% | +24.3% |